View Financial HealthBeijing Bohui Science & Technology 배당 및 자사주 매입배당 기준 점검 0/6Beijing Bohui Science & Technology 현재 배당금을 지급하지 않습니다.핵심 정보0%배당 수익률0.6%자사주 매입 수익률총 주주 수익률0.6%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향0%최근 배당 및 자사주 매입 업데이트공시 • Oct 09Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) announces an Equity Buyback for CNY 50 million worth of its shares.Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 16.18 per share. The purpose of the program is to use the repurchased shares for employee stock ownership plans or equity incentives at an appropriate time in the future. The program will be funded from company's own funds. The plan will be valid for 12 months.모든 업데이트 보기Recent updatesReported Earnings • Apr 17Full year 2025 earnings released: CN¥0.29 loss per share (vs CN¥0.48 loss in FY 2024)Full year 2025 results: CN¥0.29 loss per share (improved from CN¥0.48 loss in FY 2024). Revenue: CN¥171.0m (down 1.1% from FY 2024). Net loss: CN¥22.5m (loss narrowed 41% from FY 2024). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.공시 • Apr 17Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 08, 2026Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 08, 2026, at 14:30 China Standard Time. Location: 1F, Building 1, Yard No. 8, Linglan Road, Haidian District, Beijing China공시 • Mar 30Beijing Bohui Science & Technology Co., Ltd to Report Q1, 2026 Results on Apr 23, 2026Beijing Bohui Science & Technology Co., Ltd announced that they will report Q1, 2026 results on Apr 23, 2026공시 • Dec 26Beijing Bohui Science & Technology Co., Ltd to Report Fiscal Year 2025 Results on Apr 17, 2026Beijing Bohui Science & Technology Co., Ltd announced that they will report fiscal year 2025 results on Apr 17, 2026Reported Earnings • Oct 24Third quarter 2025 earnings released: EPS: CN¥0.037 (vs CN¥0.16 loss in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.037 (up from CN¥0.16 loss in 3Q 2024). Revenue: CN¥63.7m (up 19% from 3Q 2024). Net income: CN¥2.76m (up CN¥15.3m from 3Q 2024). Profit margin: 4.3% (up from net loss in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.New Risk • Oct 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 64% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.1% average weekly change).공시 • Sep 30Beijing Bohui Science & Technology Co., Ltd to Report Q3, 2025 Results on Oct 24, 2025Beijing Bohui Science & Technology Co., Ltd announced that they will report Q3, 2025 results on Oct 24, 2025Reported Earnings • Aug 23Second quarter 2025 earnings released: CN¥0.14 loss per share (vs CN¥0.19 loss in 2Q 2024)Second quarter 2025 results: CN¥0.14 loss per share (improved from CN¥0.19 loss in 2Q 2024). Revenue: CN¥29.3m (up 8.5% from 2Q 2024). Net loss: CN¥12.5m (loss narrowed 16% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.공시 • Jun 30Beijing Bohui Science & Technology Co., Ltd to Report First Half, 2025 Results on Aug 22, 2025Beijing Bohui Science & Technology Co., Ltd announced that they will report first half, 2025 results on Aug 22, 2025공시 • May 08Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 29, 2025Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 29, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China공시 • Apr 25Beijing Bohui Science & Technology Co., Ltd announced that it expects to receive CNY 300 million in fundingBeijing Bohui Science & Technology Co., Ltd announced a private placement to issue common shares for gross proceeds of not more than CNY 300,000,000 on April 23, 2025. The transaction has been approved by 16th meeting of the 4th Board of Directors. The shares issued to specific investors shall not be transferred within 6 months from the end of the issuance; if the investors fall under the circumstances specified in Article 57, Paragraph 2 of the "Administrative Measures for the Registration of Securities Issuance by Listed Companies," the shares they subscribe to shall not be transferred within 18 months from the end of the issuance.Reported Earnings • Apr 19Full year 2024 earnings released: CN¥0.48 loss per share (vs CN¥0.54 loss in FY 2023)Full year 2024 results: CN¥0.48 loss per share (improved from CN¥0.54 loss in FY 2023). Revenue: CN¥172.8m (down 9.9% from FY 2023). Net loss: CN¥38.5m (loss narrowed 11% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance.New Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 64% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.9% average weekly change).공시 • Mar 28Beijing Bohui Science & Technology Co., Ltd to Report Q1, 2025 Results on Apr 24, 2025Beijing Bohui Science & Technology Co., Ltd announced that they will report Q1, 2025 results on Apr 24, 2025Reported Earnings • Mar 02Full year 2024 earnings released: CN¥0.48 loss per share (vs CN¥0.54 loss in FY 2023)Full year 2024 results: CN¥0.48 loss per share (improved from CN¥0.54 loss in FY 2023). Revenue: CN¥172.8m (down 9.9% from FY 2023). Net loss: CN¥38.6m (loss narrowed 11% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance.분석 기사 • Jan 12Risks Still Elevated At These Prices As Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) Shares Dive 28%Beijing Bohui Science & Technology Co., Ltd ( SHSE:688004 ) shares have retraced a considerable 28% in the last month...공시 • Dec 27Beijing Bohui Science & Technology Co., Ltd to Report Fiscal Year 2024 Results on Apr 18, 2025Beijing Bohui Science & Technology Co., Ltd announced that they will report fiscal year 2024 results on Apr 18, 2025분석 기사 • Nov 11What Beijing Bohui Science & Technology Co., Ltd's (SHSE:688004) 39% Share Price Gain Is Not Telling YouDespite an already strong run, Beijing Bohui Science & Technology Co., Ltd ( SHSE:688004 ) shares have been powering...Reported Earnings • Oct 23Third quarter 2024 earnings released: CN¥0.16 loss per share (vs CN¥0.14 loss in 3Q 2023)Third quarter 2024 results: CN¥0.16 loss per share (further deteriorated from CN¥0.14 loss in 3Q 2023). Revenue: CN¥53.7m (up 8.3% from 3Q 2023). Net loss: CN¥12.6m (loss widened 22% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 93 percentage points per year, which is a significant difference in performance.공시 • Oct 09Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) announces an Equity Buyback for CNY 50 million worth of its shares.Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 16.18 per share. The purpose of the program is to use the repurchased shares for employee stock ownership plans or equity incentives at an appropriate time in the future. The program will be funded from company's own funds. The plan will be valid for 12 months.공시 • Sep 30Beijing Bohui Science & Technology Co., Ltd to Report Q3, 2024 Results on Oct 23, 2024Beijing Bohui Science & Technology Co., Ltd announced that they will report Q3, 2024 results on Oct 23, 2024분석 기사 • Sep 27Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) Investors Are Less Pessimistic Than ExpectedIt's not a stretch to say that Beijing Bohui Science & Technology Co., Ltd's ( SHSE:688004 ) price-to-sales (or "P/S...Reported Earnings • Aug 22Second quarter 2024 earnings released: CN¥0.19 loss per share (vs CN¥0.22 loss in 2Q 2023)Second quarter 2024 results: CN¥0.19 loss per share (improved from CN¥0.22 loss in 2Q 2023). Revenue: CN¥27.0m (down 16% from 2Q 2023). Net loss: CN¥14.8m (loss narrowed 25% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.공시 • Jun 29Beijing Bohui Science & Technology Co., Ltd to Report First Half, 2024 Results on Aug 22, 2024Beijing Bohui Science & Technology Co., Ltd announced that they will report first half, 2024 results on Aug 22, 2024분석 기사 • Jun 06Risks Still Elevated At These Prices As Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) Shares Dive 25%Unfortunately for some shareholders, the Beijing Bohui Science & Technology Co., Ltd ( SHSE:688004 ) share price has...공시 • Apr 26Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 15, 2024Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 15, 2024, at 14:00 China Standard Time. Location: Building 8, Yard No. 5, Rendong Road, Haidian District, Beijing ChinaReported Earnings • Apr 18Full year 2023 earnings released: CN¥0.76 loss per share (vs CN¥0.50 loss in FY 2022)Full year 2023 results: CN¥0.76 loss per share (further deteriorated from CN¥0.50 loss in FY 2022). Revenue: CN¥191.8m (up 17% from FY 2022). Net loss: CN¥43.2m (loss widened 52% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.공시 • Mar 29Beijing Bohui Science & Technology Co., Ltd to Report Q1, 2024 Results on Apr 25, 2024Beijing Bohui Science & Technology Co., Ltd announced that they will report Q1, 2024 results on Apr 25, 2024분석 기사 • Mar 07Beijing Bohui Science & Technology Co., Ltd's (SHSE:688004) 36% Price Boost Is Out Of Tune With RevenuesBeijing Bohui Science & Technology Co., Ltd ( SHSE:688004 ) shareholders are no doubt pleased to see that the share...Reported Earnings • Feb 28Full year 2023 earnings released: CN¥0.74 loss per share (vs CN¥0.50 loss in FY 2022)Full year 2023 results: CN¥0.74 loss per share (further deteriorated from CN¥0.50 loss in FY 2022). Revenue: CN¥181.4m (up 11% from FY 2022). Net loss: CN¥42.1m (loss widened 48% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance.New Risk • Jan 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 55% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.3% average weekly change).Board Change • Jan 10Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Feng Lin was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Dec 29Beijing Bohui Science & Technology Co., Ltd to Report Fiscal Year 2023 Results on Apr 18, 2024Beijing Bohui Science & Technology Co., Ltd announced that they will report fiscal year 2023 results on Apr 18, 2024Reported Earnings • Oct 20Third quarter 2023 earnings released: CN¥0.19 loss per share (vs CN¥0.071 loss in 3Q 2022)Third quarter 2023 results: CN¥0.19 loss per share (further deteriorated from CN¥0.071 loss in 3Q 2022). Revenue: CN¥49.6m (up 5.3% from 3Q 2022). Net loss: CN¥10.3m (loss widened 155% from 3Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.공시 • Sep 30Beijing Bohui Science & Technology Co., Ltd to Report Q3, 2023 Results on Oct 19, 2023Beijing Bohui Science & Technology Co., Ltd announced that they will report Q3, 2023 results on Oct 19, 2023Reported Earnings • Aug 25Second quarter 2023 earnings released: CN¥0.31 loss per share (vs CN¥0.36 loss in 2Q 2022)Second quarter 2023 results: CN¥0.31 loss per share (improved from CN¥0.36 loss in 2Q 2022). Revenue: CN¥32.0m (up 228% from 2Q 2022). Net loss: CN¥19.8m (loss narrowed 6.4% from 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.Reported Earnings • Apr 12Full year 2022 earnings released: CN¥0.50 loss per share (vs CN¥0.87 profit in FY 2021)Full year 2022 results: CN¥0.50 loss per share (down from CN¥0.87 profit in FY 2021). Revenue: CN¥164.0m (down 43% from FY 2021). Net loss: CN¥28.4m (down 158% from profit in FY 2021).Board Change • Nov 16Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Guangzhi Wang was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.Reported Earnings • Oct 25Third quarter 2022 earnings released: CN¥0.071 loss per share (vs CN¥0.02 profit in 3Q 2021)Third quarter 2022 results: CN¥0.071 loss per share (down from CN¥0.02 profit in 3Q 2021). Revenue: CN¥47.1m (down 8.4% from 3Q 2021). Net loss: CN¥4.04m (down 465% from profit in 3Q 2021).Reported Earnings • Aug 26Second quarter 2022 earnings released: CN¥0.36 loss per share (vs CN¥0.35 profit in 2Q 2021)Second quarter 2022 results: CN¥0.36 loss per share (down from CN¥0.35 profit in 2Q 2021). Revenue: CN¥9.76m (down 89% from 2Q 2021). Net loss: CN¥21.2m (down 204% from profit in 2Q 2021).Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥26.69, the stock trades at a trailing P/E ratio of 31.5x. Average trailing P/E is 52x in the Software industry in China. Total loss to shareholders of 33% over the past year.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Apr 12Full year 2021 earnings released: EPS: CN¥0.87 (vs CN¥0.93 in FY 2020)Full year 2021 results: EPS: CN¥0.87. Revenue: CN¥287.1m (flat on FY 2020). Net income: CN¥49.2m (up 5.9% from FY 2020). Profit margin: 17% (up from 16% in FY 2020).Reported Earnings • Feb 28Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: CN¥1.86 (up from CN¥0.93 in FY 2020). Revenue: CN¥405.9m (up 41% from FY 2020). Net income: CN¥136.1m (up 193% from FY 2020). Profit margin: 34% (up from 16% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates.Reported Earnings • Oct 25Third quarter 2021 earnings released: EPS CN¥0.02 (vs CN¥0.02 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥51.3m (up 20% from 3Q 2020). Net income: CN¥1.11m (down 15% from 3Q 2020). Profit margin: 2.2% (down from 3.1% in 3Q 2020). The decrease in margin was driven by higher expenses.Reported Earnings • Aug 20Second quarter 2021 earnings released: EPS CN¥0.35 (vs CN¥0.30 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥89.2m (up 6.3% from 2Q 2020). Net income: CN¥20.4m (up 21% from 2Q 2020). Profit margin: 23% (up from 20% in 2Q 2020). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Aug 03Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥38.88, the stock trades at a trailing P/E ratio of 47.5x. Average trailing P/E is 51x in the Software industry in China. Total loss to shareholders of 51% over the past year.Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 23% share price gain to CN¥43.66, the stock trades at a trailing P/E ratio of 53.3x. Average trailing P/E is 51x in the Software industry in China.Reported Earnings • Apr 20Full year 2020 earnings released: EPS CN¥0.93 (vs CN¥1.20 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥287.9m (up 4.8% from FY 2019). Net income: CN¥46.4m (down 8.8% from FY 2019). Profit margin: 16% (down from 19% in FY 2019). The decrease in margin was driven by higher expenses.Is New 90 Day High Low • Feb 04New 90-day low: CN¥39.01The company is down 37% from its price of CN¥61.67 on 05 November 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 2.0% over the same period.Is New 90 Day High Low • Jan 07New 90-day low: CN¥43.49The company is down 35% from its price of CN¥67.18 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 1.0% over the same period.Is New 90 Day High Low • Dec 15New 90-day low: CN¥51.69The company is down 22% from its price of CN¥66.50 on 16 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 5.0% over the same period.Is New 90 Day High Low • Nov 27New 90-day low: CN¥58.65The company is down 24% from its price of CN¥77.24 on 28 August 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 11% over the same period.Is New 90 Day High Low • Oct 30New 90-day low: CN¥61.80The company is down 24% from its price of CN¥81.00 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 12% over the same period.Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥55.2m, up 6.4% from the prior year. Total revenue was CN¥287.5m over the last 12 months, up 3.8% from the prior year.공시 • Oct 19Beijing Bohui Science & Technology Co., Ltd. to Report Q3, 2020 Results on Oct 20, 2020Beijing Bohui Science & Technology Co., Ltd. announced that they will report Q3, 2020 results on Oct 20, 2020공시 • Jul 09Beijing Bohui Science & Technology Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020Beijing Bohui Science & Technology Co., Ltd. announced that they will report first half, 2020 results on Aug 25, 2020지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 688004 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: 688004 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Beijing Bohui Science & Technology 배당 수익률 vs 시장688004의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (688004)0%시장 하위 25% (CN)0.4%시장 상위 25% (CN)1.9%업계 평균 (Software)0.6%분석가 예측 (688004) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 688004 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 688004 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 688004 CN 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: 688004 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YCN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 21:18종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Beijing Bohui Science & Technology Co., Ltd는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Oct 09Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) announces an Equity Buyback for CNY 50 million worth of its shares.Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 16.18 per share. The purpose of the program is to use the repurchased shares for employee stock ownership plans or equity incentives at an appropriate time in the future. The program will be funded from company's own funds. The plan will be valid for 12 months.
Reported Earnings • Apr 17Full year 2025 earnings released: CN¥0.29 loss per share (vs CN¥0.48 loss in FY 2024)Full year 2025 results: CN¥0.29 loss per share (improved from CN¥0.48 loss in FY 2024). Revenue: CN¥171.0m (down 1.1% from FY 2024). Net loss: CN¥22.5m (loss narrowed 41% from FY 2024). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
공시 • Apr 17Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 08, 2026Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 08, 2026, at 14:30 China Standard Time. Location: 1F, Building 1, Yard No. 8, Linglan Road, Haidian District, Beijing China
공시 • Mar 30Beijing Bohui Science & Technology Co., Ltd to Report Q1, 2026 Results on Apr 23, 2026Beijing Bohui Science & Technology Co., Ltd announced that they will report Q1, 2026 results on Apr 23, 2026
공시 • Dec 26Beijing Bohui Science & Technology Co., Ltd to Report Fiscal Year 2025 Results on Apr 17, 2026Beijing Bohui Science & Technology Co., Ltd announced that they will report fiscal year 2025 results on Apr 17, 2026
Reported Earnings • Oct 24Third quarter 2025 earnings released: EPS: CN¥0.037 (vs CN¥0.16 loss in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.037 (up from CN¥0.16 loss in 3Q 2024). Revenue: CN¥63.7m (up 19% from 3Q 2024). Net income: CN¥2.76m (up CN¥15.3m from 3Q 2024). Profit margin: 4.3% (up from net loss in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.
New Risk • Oct 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 64% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.1% average weekly change).
공시 • Sep 30Beijing Bohui Science & Technology Co., Ltd to Report Q3, 2025 Results on Oct 24, 2025Beijing Bohui Science & Technology Co., Ltd announced that they will report Q3, 2025 results on Oct 24, 2025
Reported Earnings • Aug 23Second quarter 2025 earnings released: CN¥0.14 loss per share (vs CN¥0.19 loss in 2Q 2024)Second quarter 2025 results: CN¥0.14 loss per share (improved from CN¥0.19 loss in 2Q 2024). Revenue: CN¥29.3m (up 8.5% from 2Q 2024). Net loss: CN¥12.5m (loss narrowed 16% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.
공시 • Jun 30Beijing Bohui Science & Technology Co., Ltd to Report First Half, 2025 Results on Aug 22, 2025Beijing Bohui Science & Technology Co., Ltd announced that they will report first half, 2025 results on Aug 22, 2025
공시 • May 08Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 29, 2025Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 29, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Beijing China
공시 • Apr 25Beijing Bohui Science & Technology Co., Ltd announced that it expects to receive CNY 300 million in fundingBeijing Bohui Science & Technology Co., Ltd announced a private placement to issue common shares for gross proceeds of not more than CNY 300,000,000 on April 23, 2025. The transaction has been approved by 16th meeting of the 4th Board of Directors. The shares issued to specific investors shall not be transferred within 6 months from the end of the issuance; if the investors fall under the circumstances specified in Article 57, Paragraph 2 of the "Administrative Measures for the Registration of Securities Issuance by Listed Companies," the shares they subscribe to shall not be transferred within 18 months from the end of the issuance.
Reported Earnings • Apr 19Full year 2024 earnings released: CN¥0.48 loss per share (vs CN¥0.54 loss in FY 2023)Full year 2024 results: CN¥0.48 loss per share (improved from CN¥0.54 loss in FY 2023). Revenue: CN¥172.8m (down 9.9% from FY 2023). Net loss: CN¥38.5m (loss narrowed 11% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance.
New Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 64% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.9% average weekly change).
공시 • Mar 28Beijing Bohui Science & Technology Co., Ltd to Report Q1, 2025 Results on Apr 24, 2025Beijing Bohui Science & Technology Co., Ltd announced that they will report Q1, 2025 results on Apr 24, 2025
Reported Earnings • Mar 02Full year 2024 earnings released: CN¥0.48 loss per share (vs CN¥0.54 loss in FY 2023)Full year 2024 results: CN¥0.48 loss per share (improved from CN¥0.54 loss in FY 2023). Revenue: CN¥172.8m (down 9.9% from FY 2023). Net loss: CN¥38.6m (loss narrowed 11% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance.
분석 기사 • Jan 12Risks Still Elevated At These Prices As Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) Shares Dive 28%Beijing Bohui Science & Technology Co., Ltd ( SHSE:688004 ) shares have retraced a considerable 28% in the last month...
공시 • Dec 27Beijing Bohui Science & Technology Co., Ltd to Report Fiscal Year 2024 Results on Apr 18, 2025Beijing Bohui Science & Technology Co., Ltd announced that they will report fiscal year 2024 results on Apr 18, 2025
분석 기사 • Nov 11What Beijing Bohui Science & Technology Co., Ltd's (SHSE:688004) 39% Share Price Gain Is Not Telling YouDespite an already strong run, Beijing Bohui Science & Technology Co., Ltd ( SHSE:688004 ) shares have been powering...
Reported Earnings • Oct 23Third quarter 2024 earnings released: CN¥0.16 loss per share (vs CN¥0.14 loss in 3Q 2023)Third quarter 2024 results: CN¥0.16 loss per share (further deteriorated from CN¥0.14 loss in 3Q 2023). Revenue: CN¥53.7m (up 8.3% from 3Q 2023). Net loss: CN¥12.6m (loss widened 22% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 93 percentage points per year, which is a significant difference in performance.
공시 • Oct 09Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) announces an Equity Buyback for CNY 50 million worth of its shares.Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 16.18 per share. The purpose of the program is to use the repurchased shares for employee stock ownership plans or equity incentives at an appropriate time in the future. The program will be funded from company's own funds. The plan will be valid for 12 months.
공시 • Sep 30Beijing Bohui Science & Technology Co., Ltd to Report Q3, 2024 Results on Oct 23, 2024Beijing Bohui Science & Technology Co., Ltd announced that they will report Q3, 2024 results on Oct 23, 2024
분석 기사 • Sep 27Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) Investors Are Less Pessimistic Than ExpectedIt's not a stretch to say that Beijing Bohui Science & Technology Co., Ltd's ( SHSE:688004 ) price-to-sales (or "P/S...
Reported Earnings • Aug 22Second quarter 2024 earnings released: CN¥0.19 loss per share (vs CN¥0.22 loss in 2Q 2023)Second quarter 2024 results: CN¥0.19 loss per share (improved from CN¥0.22 loss in 2Q 2023). Revenue: CN¥27.0m (down 16% from 2Q 2023). Net loss: CN¥14.8m (loss narrowed 25% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
공시 • Jun 29Beijing Bohui Science & Technology Co., Ltd to Report First Half, 2024 Results on Aug 22, 2024Beijing Bohui Science & Technology Co., Ltd announced that they will report first half, 2024 results on Aug 22, 2024
분석 기사 • Jun 06Risks Still Elevated At These Prices As Beijing Bohui Science & Technology Co., Ltd (SHSE:688004) Shares Dive 25%Unfortunately for some shareholders, the Beijing Bohui Science & Technology Co., Ltd ( SHSE:688004 ) share price has...
공시 • Apr 26Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 15, 2024Beijing Bohui Science & Technology Co., Ltd, Annual General Meeting, May 15, 2024, at 14:00 China Standard Time. Location: Building 8, Yard No. 5, Rendong Road, Haidian District, Beijing China
Reported Earnings • Apr 18Full year 2023 earnings released: CN¥0.76 loss per share (vs CN¥0.50 loss in FY 2022)Full year 2023 results: CN¥0.76 loss per share (further deteriorated from CN¥0.50 loss in FY 2022). Revenue: CN¥191.8m (up 17% from FY 2022). Net loss: CN¥43.2m (loss widened 52% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
공시 • Mar 29Beijing Bohui Science & Technology Co., Ltd to Report Q1, 2024 Results on Apr 25, 2024Beijing Bohui Science & Technology Co., Ltd announced that they will report Q1, 2024 results on Apr 25, 2024
분석 기사 • Mar 07Beijing Bohui Science & Technology Co., Ltd's (SHSE:688004) 36% Price Boost Is Out Of Tune With RevenuesBeijing Bohui Science & Technology Co., Ltd ( SHSE:688004 ) shareholders are no doubt pleased to see that the share...
Reported Earnings • Feb 28Full year 2023 earnings released: CN¥0.74 loss per share (vs CN¥0.50 loss in FY 2022)Full year 2023 results: CN¥0.74 loss per share (further deteriorated from CN¥0.50 loss in FY 2022). Revenue: CN¥181.4m (up 11% from FY 2022). Net loss: CN¥42.1m (loss widened 48% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance.
New Risk • Jan 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 55% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.3% average weekly change).
Board Change • Jan 10Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Feng Lin was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Dec 29Beijing Bohui Science & Technology Co., Ltd to Report Fiscal Year 2023 Results on Apr 18, 2024Beijing Bohui Science & Technology Co., Ltd announced that they will report fiscal year 2023 results on Apr 18, 2024
Reported Earnings • Oct 20Third quarter 2023 earnings released: CN¥0.19 loss per share (vs CN¥0.071 loss in 3Q 2022)Third quarter 2023 results: CN¥0.19 loss per share (further deteriorated from CN¥0.071 loss in 3Q 2022). Revenue: CN¥49.6m (up 5.3% from 3Q 2022). Net loss: CN¥10.3m (loss widened 155% from 3Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.
공시 • Sep 30Beijing Bohui Science & Technology Co., Ltd to Report Q3, 2023 Results on Oct 19, 2023Beijing Bohui Science & Technology Co., Ltd announced that they will report Q3, 2023 results on Oct 19, 2023
Reported Earnings • Aug 25Second quarter 2023 earnings released: CN¥0.31 loss per share (vs CN¥0.36 loss in 2Q 2022)Second quarter 2023 results: CN¥0.31 loss per share (improved from CN¥0.36 loss in 2Q 2022). Revenue: CN¥32.0m (up 228% from 2Q 2022). Net loss: CN¥19.8m (loss narrowed 6.4% from 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.
Reported Earnings • Apr 12Full year 2022 earnings released: CN¥0.50 loss per share (vs CN¥0.87 profit in FY 2021)Full year 2022 results: CN¥0.50 loss per share (down from CN¥0.87 profit in FY 2021). Revenue: CN¥164.0m (down 43% from FY 2021). Net loss: CN¥28.4m (down 158% from profit in FY 2021).
Board Change • Nov 16Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Guangzhi Wang was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
Reported Earnings • Oct 25Third quarter 2022 earnings released: CN¥0.071 loss per share (vs CN¥0.02 profit in 3Q 2021)Third quarter 2022 results: CN¥0.071 loss per share (down from CN¥0.02 profit in 3Q 2021). Revenue: CN¥47.1m (down 8.4% from 3Q 2021). Net loss: CN¥4.04m (down 465% from profit in 3Q 2021).
Reported Earnings • Aug 26Second quarter 2022 earnings released: CN¥0.36 loss per share (vs CN¥0.35 profit in 2Q 2021)Second quarter 2022 results: CN¥0.36 loss per share (down from CN¥0.35 profit in 2Q 2021). Revenue: CN¥9.76m (down 89% from 2Q 2021). Net loss: CN¥21.2m (down 204% from profit in 2Q 2021).
Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥26.69, the stock trades at a trailing P/E ratio of 31.5x. Average trailing P/E is 52x in the Software industry in China. Total loss to shareholders of 33% over the past year.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Apr 12Full year 2021 earnings released: EPS: CN¥0.87 (vs CN¥0.93 in FY 2020)Full year 2021 results: EPS: CN¥0.87. Revenue: CN¥287.1m (flat on FY 2020). Net income: CN¥49.2m (up 5.9% from FY 2020). Profit margin: 17% (up from 16% in FY 2020).
Reported Earnings • Feb 28Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: CN¥1.86 (up from CN¥0.93 in FY 2020). Revenue: CN¥405.9m (up 41% from FY 2020). Net income: CN¥136.1m (up 193% from FY 2020). Profit margin: 34% (up from 16% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates.
Reported Earnings • Oct 25Third quarter 2021 earnings released: EPS CN¥0.02 (vs CN¥0.02 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥51.3m (up 20% from 3Q 2020). Net income: CN¥1.11m (down 15% from 3Q 2020). Profit margin: 2.2% (down from 3.1% in 3Q 2020). The decrease in margin was driven by higher expenses.
Reported Earnings • Aug 20Second quarter 2021 earnings released: EPS CN¥0.35 (vs CN¥0.30 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥89.2m (up 6.3% from 2Q 2020). Net income: CN¥20.4m (up 21% from 2Q 2020). Profit margin: 23% (up from 20% in 2Q 2020). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Aug 03Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥38.88, the stock trades at a trailing P/E ratio of 47.5x. Average trailing P/E is 51x in the Software industry in China. Total loss to shareholders of 51% over the past year.
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 23% share price gain to CN¥43.66, the stock trades at a trailing P/E ratio of 53.3x. Average trailing P/E is 51x in the Software industry in China.
Reported Earnings • Apr 20Full year 2020 earnings released: EPS CN¥0.93 (vs CN¥1.20 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥287.9m (up 4.8% from FY 2019). Net income: CN¥46.4m (down 8.8% from FY 2019). Profit margin: 16% (down from 19% in FY 2019). The decrease in margin was driven by higher expenses.
Is New 90 Day High Low • Feb 04New 90-day low: CN¥39.01The company is down 37% from its price of CN¥61.67 on 05 November 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 2.0% over the same period.
Is New 90 Day High Low • Jan 07New 90-day low: CN¥43.49The company is down 35% from its price of CN¥67.18 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 1.0% over the same period.
Is New 90 Day High Low • Dec 15New 90-day low: CN¥51.69The company is down 22% from its price of CN¥66.50 on 16 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 5.0% over the same period.
Is New 90 Day High Low • Nov 27New 90-day low: CN¥58.65The company is down 24% from its price of CN¥77.24 on 28 August 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 11% over the same period.
Is New 90 Day High Low • Oct 30New 90-day low: CN¥61.80The company is down 24% from its price of CN¥81.00 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 12% over the same period.
Reported Earnings • Oct 26Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥55.2m, up 6.4% from the prior year. Total revenue was CN¥287.5m over the last 12 months, up 3.8% from the prior year.
공시 • Oct 19Beijing Bohui Science & Technology Co., Ltd. to Report Q3, 2020 Results on Oct 20, 2020Beijing Bohui Science & Technology Co., Ltd. announced that they will report Q3, 2020 results on Oct 20, 2020
공시 • Jul 09Beijing Bohui Science & Technology Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020Beijing Bohui Science & Technology Co., Ltd. announced that they will report first half, 2020 results on Aug 25, 2020